<?xml version="1.0" encoding="UTF-8"?>
<ref id="B45-medicines-04-00034" class="ref">
 <label class="label">45.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Park</surname>
    <given-names class="given-names">K.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Nam</surname>
    <given-names class="given-names">D.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Yun</surname>
    <given-names class="given-names">H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Lee</surname>
    <given-names class="given-names">S.G.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Jang</surname>
    <given-names class="given-names">H.J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Sethi</surname>
    <given-names class="given-names">G.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Cho</surname>
    <given-names class="given-names">S.K.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ahn</surname>
    <given-names class="given-names">K.S.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Î²-caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation</article-title>
  <source class="source">Cancer Lett.</source>
  <year class="year">2011</year>
  <volume class="volume">312</volume>
  <fpage class="fpage">178</fpage>
  <lpage class="lpage">188</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.canlet.2011.08.001</pub-id>
  <?supplied-pmid 21924548?>
  <pub-id pub-id-type="pmid" class="pub-id">21924548</pub-id>
 </element-citation>
</ref>
